Baird Medical Investment Holdings (BDMD) Non-Current Debt (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has reported Non-Current Debt for 3 consecutive years, with $6.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Non-Current Debt rose 76.8% year-over-year to $6.1 million in Q4 2025; TTM through Dec 2025 was $6.1 million, a 76.8% increase from a year earlier, with the FY2025 full-year figure at $6.1 million, up 76.8% from the prior year.
• Non-Current Debt was $6.1 million for Q4 2025 at Baird Medical Investment Holdings, up from $5.8 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $6.1 million in Q4 2025 and troughed at $1.6 million in Q4 2023.
• A 3-year average of $4.2 million and a median of $4.6 million in 2024 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt surged 113.35% in 2024 and soared 76.8% in 2025, its largest moves.
• Over 3 years, Non-Current Debt stood at $1.6 million in 2023, then soared by 113.35% to $3.4 million in 2024, then soared by 76.8% to $6.1 million in 2025.
• The last three Non-Current Debt figures came in at $6.1 million (Q4 2025), $5.8 million (Q2 2025), and $3.4 million (Q4 2024), per Business Quant data.